This site is intended for healthcare professionals only
LoginRegister
Cipla Bommasandra facility gets VAI classification from USFDACDSCO Panel Clears Cipla's Glycopyrronium-Formoterol Inhaler for Phase IV Trial
Natco Pharma offers to acquire stake in South African pharma firm Adcock Ingram HoldingsNatco Pharma offers to acquire stake in South African pharma firm Adcock Ingram Holdings for Rs 2000...
USFDA approves Zydus Lifesciences chronic idiopathic constipation drug PrucaloprideDelhi HC Bars Zydus From Launching Cancer Drug Nivolumab Biosimilar Till 2026
Syngene International names Chethan Yogesh as Company Secretary, Compliance OfficerSyngene International names Chethan Yogesh as Company Secretary, Compliance Officer
Veeda Clinical Research Gets Expert Committee Nod To Conduct BA/BE Study Of Ibrutinib For ExportNumber of schemes being implemented to realise vision of Atmanirbhar Bharat in pharma sector:...
Deepali NaairBiocon Biologics appoints Deepali Naair as Global Head - Brand & Corporate Communications
Morepen Labs incorporates new step-down subsidiary in mainland DubaiMorepen Labs incorporates new step-down subsidiary in mainland Dubai
Biocon, NCSM partnerBiocon Biologics launches Nepexto in Australia
Zydus Secures CDSCO Panel Go-Ahead For Phase III Trial of Empagliflozin-Metoprolol FDCZydus Secures CDSCO Panel Go-Ahead For Phase III Trial of Empagliflozin-Metoprolol FDC
Karandeep Singh DuggalReckitt names Karandeep Singh Duggal as new Region Head-Central India
Cipla inks pacts to invest in iCaltech InnovationsCipla inks pacts to invest in iCaltech Innovations
Takeda gets USFDA 510(k) clearance for HyHub, HyHub Duo devices to simplify HYQVIA administrationTakeda gets USFDA 510(k) clearance for HyHub, HyHub Duo devices to simplify HYQVIA administration
X